ServiceNow (NOW) 10-Q 27 Apr 22 2022 Q1 Quarterly report Financial data

Cover

Cover shares in Millions	3 Months Ended
	Mar. 31, 2022shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-35580
Entity Registrant Name	SERVICENOW, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2056195
Entity Address, Address Line One	2225 Lawson Lane
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	408
Local Phone Number	501-8550
Title of 12(b) Security	Common stock, par value $0.001 per share
Trading Symbol	NOW
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	200
Entity Central Index Key	0001373715
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 2,252	$ 1,728
Short-term investments	1,762	1,576
Accounts receivable, net	824	1,390
Current portion of deferred commissions	322	303
Prepaid expenses and other current assets	282	223
Total current assets	5,442	5,220
Deferred commissions, less current portion	655	623
Long-term investments	1,484	1,630
Property and equipment, net	798	766
Operating lease right-of-use assets	583	591
Intangible assets, net	266	287
Goodwill	774	777
Deferred tax assets	686	692
Other assets	305	212
Total assets	10,993	10,798
Current liabilities:
Accounts payable	166	89
Accrued expenses and other current liabilities	661	850
Current portion of deferred revenue	3,850	3,836
Current portion of operating lease liabilities	87	82
Current debt, net	88	92
Total current liabilities	4,852	4,949
Deferred revenue, less current portion	57	63
Operating lease liabilities, less current portion	548	556
Long-term debt, net	1,484	1,484
Other long-term liabilities	55	51
Total liabilities	6,996	7,103
Commitments and contingencies
Stockholders’ equity:
Common stock	0	0
Additional paid-in capital	3,925	3,665
Accumulated other comprehensive income/(loss)	(16)	34
Retained earnings (accumulated deficit)	88	(4)
Total stockholders’ equity	3,997	3,695
Total liabilities and stockholders’ equity	$ 10,993	$ 10,798

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
Revenues:
Total revenues		$ 1,722,000	$ 1,360,000
Cost of revenues:
Total cost of revenues	[1]	369,000	299,000
Gross profit		1,353,000	1,061,000
Operating expenses:
Sales and marketing	[1]	673,000	524,000
Research and development	[1]	414,000	314,000
General and administrative	[1]	179,000	126,000
Total operating expenses	[1]	1,266,000	964,000
Income from operations		87,000	97,000
Interest expense		(6,000)	(7,000)
Other income, net		4,000	9,000
Income before income taxes		85,000	99,000
Provision for income taxes		10,000	17,000
Net income		$ 75,350	$ 82,440
Net income per share - basic (in USD per share)		$ 0.38	$ 0.42
Net income per share - diluted (in USD per share)		$ 0.37	$ 0.41
Weighted-average shares used to compute net income per share - basic (in shares)		200,088	196,624
Weighted-average shares used to compute net income per share - diluted (in shares)		202,800	202,268
Other comprehensive loss:
Foreign currency translation adjustments		$ (12,000)	$ (31,000)
Unrealized losses on investments, net of tax		(38,000)	(7,000)
Other comprehensive loss		(50,000)	(38,000)
Comprehensive income		25,000	44,000
Subscription
Revenues:
Total revenues		1,631,000	1,293,000
Cost of revenues:
Total cost of revenues	[1]	275,000	228,000
Professional services and other
Revenues:
Total revenues		91,000	67,000
Cost of revenues:
Total cost of revenues	[1]	$ 94,000	$ 71,000
[1]	Includes stock-based compensation as follows: Three Months Ended March 31, 2022 2021 Cost of revenues: Subscription $ 36 $ 29 Professional services and other $ 16 $ 13 Operating expenses: Sales and marketing $ 105 $ 93 Research and development $ 115 $ 88 General and administrative $ 53 $ 33

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Stock-based compensation	$ 325	$ 256
Cost of revenues | Subscription
Stock-based compensation	36	29
Cost of revenues | Professional services and other
Stock-based compensation	16	13
Sales and marketing
Stock-based compensation	105	93
Research and development
Stock-based compensation	115	88
General and administrative
Stock-based compensation	$ 53	$ 33

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period Of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in CapitalCumulative Effect, Period Of Adoption, Adjustment	Retained Earnings (Accumulated Deficit)	Retained Earnings (Accumulated Deficit)Cumulative Effect, Period Of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020			195,845
Beginning balance at Dec. 31, 2020	$ 2,834,000		$ 0	$ 2,974,000		$ (234,000)		$ 94,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee stock plans (in shares)	1,100		1,066
Common stock issued under employee stock plans	$ 94,000			94,000
Taxes paid related to net share settlement of equity awards	(191,000)			(191,000)
Stock-based compensation	256,000			256,000
Settlement of 2022 Warrants (in shares)			536
Settlement of 2022 Warrants	0
Settlement of 2022 Notes conversion feature	(102,000)			(102,000)
Benefit from exercise of 2022 Note Hedge	102,000			102,000
Other comprehensive loss, net of tax	(38,000)							(38,000)
Net income	82,440					82,000
Ending balance (in shares) at Mar. 31, 2021			197,447
Ending balance at Mar. 31, 2021	3,037,000		$ 0	3,133,000		(152,000)		56,000
Beginning balance (in shares) at Dec. 31, 2020			195,845
Beginning balance at Dec. 31, 2020	$ 2,834,000		$ 0	2,974,000		(234,000)		94,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06
Ending balance (in shares) at Dec. 31, 2021			199,608
Ending balance at Dec. 31, 2021	$ 3,695,000	$ (2,000)	$ 0	3,665,000	$ (19,000)	(4,000)	$ 17,000	34,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee stock plans (in shares)	800		849
Common stock issued under employee stock plans	$ 105,000			105,000
Taxes paid related to net share settlement of equity awards	(150,000)			(150,000)
Stock-based compensation	324,000			324,000
Settlement of 2022 Notes conversion feature	(21,000)			(21,000)
Benefit from exercise of 2022 Note Hedge	21,000			21,000
Other comprehensive loss, net of tax	(50,000)							(50,000)
Net income	75,350					75,000
Ending balance (in shares) at Mar. 31, 2022			200,457
Ending balance at Mar. 31, 2022	$ 3,997,000		$ 0	$ 3,925,000		$ 88,000		$ (16,000)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 75,350	$ 82,440
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	101,000	106,000
Amortization of deferred commissions	83,000	66,000
Stock-based compensation	325,000	256,000
Deferred income taxes	(2,000)	1,000
Repayments of convertible senior notes attributable to debt discount	0	(7,000)
Other	15,000	17,000
Changes in operating assets and liabilities, net of effect of business combinations:
Accounts receivable	562,000	354,000
Deferred commissions	(137,000)	(114,000)
Prepaid expenses and other assets	(46,000)	(3,000)
Accounts payable	69,000	89,000
Deferred revenue	21,000	75,000
Accrued expenses and other liabilities	(203,000)	(195,000)
Net cash provided by operating activities	863,000	727,000
Cash flows from investing activities:
Purchases of property and equipment	(93,000)	(107,000)
Business combinations, net of cash acquired	0	(225,000)
Purchases of investments	(662,000)	(644,000)
Purchases of non-marketable investments	(101,000)	0
Sales and maturities of investments	577,000	532,000
Others	(1,000)	7,000
Net cash used in investing activities	(280,000)	(437,000)
Cash flows from financing activities:
Repayments of convertible senior notes attributable to principal	(6,000)	(28,000)
Proceeds from employee stock plans	105,000	95,000
Taxes paid related to net share settlement of equity awards	(150,000)	(191,000)
Net cash used in financing activities	(51,000)	(124,000)
Foreign currency effect on cash, cash equivalents and restricted cash	(5,000)	(18,000)
Net change in cash, cash equivalents and restricted cash	527,000	148,000
Cash, cash equivalents and restricted cash at beginning of period	1,732,000	1,679,000
Cash, cash equivalents and restricted cash at end of period	2,259,000	1,827,000
Cash, cash equivalents and restricted cash at end of period:
Cash and cash equivalents	2,252,000	1,821,000
Restricted cash included in prepaid expenses and other current assets	7,000	6,000
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	2,259,000	1,827,000
Supplemental disclosures of other cash flow information:
Interest paid	11,000	15,000
Income taxes paid, net of refunds	9,000	12,000
Non-cash investing and financing activities:
Settlement of 2022 Notes conversion feature	21,000	102,000
Benefit from exercise of 2022 Note Hedge	21,000	102,000
Property and equipment included in accounts payable, accrued expenses and other liabilities	$ 73,000	$ 28,000

Description of the Business

Description of the Business	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of the Business	Description of the BusinessServiceNow was founded on a simple premise: a better technology platform will help work flow better. We help global enterprises across industries, universities and governments to digitize their workflows. We categorize the workflows we provide into four primary areas: Technology (formerly known as Information Technology), Employee, Customer and Creator. The products under each of our workflows help customers connect work across systems and silos to enable great experiences for people. The Now Platform is uniquely positioned to enable our customers’ digital transformation from non-integrated enterprise technology solutions with manual and disconnected processes and activities, to integrated enterprise technology solutions with automation and connected processes and activities which increases our customers’ resiliency and security and delivers additional value to their employees and consumers.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements and condensed footnotes have been prepared in accordance with the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements due to the permitted exclusion of certain disclosures for interim reporting. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary under GAAP for fair statement of results for the interim periods presented have been included. As a result of displaying amounts in millions, rounding differences may exist in the consolidated financial statements and footnote tables. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for other interim periods or future years. The condensed consolidated balance sheet as of December 31, 2021 is derived from audited consolidated financial statements; however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 3, 2022. Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, and include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenues and expenses during the reporting period. Such management estimates and assumptions include, but are not limited to, standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations, the period of benefit for deferred commissions, valuation of intangible assets, the useful life of property and equipment and identifiable intangible assets, stock-based compensation expense and income taxes. Actual results could differ from those estimates. We assessed the impact of COVID-19 on the estimates and assumptions and determined there was no material impact. In January 2022, we completed an assessment of the useful life of our data center equipment and determined we should increase the estimated useful life of data center equipment from three years to four years. This change in accounting estimate was effective beginning fiscal year 2022. Based on the carrying amount of data center equipment included in property and equipment, net as of December 31, 2021, the effect of this change in estimate for the three months ended March 31, 2022, was a reduction in depreciation expense of $21 million and an increase in net income of $20 million, or $0.10 per share basic and diluted. Significant Accounting Policies There were no significant changes to our significant accounting policies disclosed in “Note 2 – Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 3, 2022, other than the change in useful life of our data center equipment, discussed above. Concentration of Credit Risk and Significant Customers Credit risk arising from accounts receivable is mitigated to a certain extent due to our large number of customers and their dispersion across various industries and geographies. As of March 31, 2022, we had one customer, a channel partner, that represented 10% of our accounts receivable. As of December 31, 2021, there were no customers that represented more than 10% of our accounts receivable balance. Further, there were no customers that individually exceeded 10% of our total revenues in any of the periods presented. Our customers in Russia represented an immaterial portion of our total consolidated revenues and our accounts receivable balance in any of the periods presented. For purposes of assessing concentration of credit risk and significant customers, a group of customers under common control or customers that are affiliates of each other are regarded as a single customer. Recently Adopted Accounting Pronouncement Debt with Conversion Options In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, “Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40)” to simplify the accounting for convertible instruments and contracts on an entity’s own equity. The standard results in our 2022 Notes being accounted for as a single unit of debt and requires the if-converted method to calculate diluted earnings per share calculation. We adopted this standard effective January 1, 2022 using a modified retrospective method, under which the basis of all convertible instruments outstanding at adoption have been adjusted to the amounts that would have been recorded had the new guidance been applied from inception. The previously recorded equity component of the convertible instrument outstanding and amortization of the debt discount and issuance costs classified as equity are reclassified from equity to debt through an adjustment to the opening balance of accumulated deficit as of January 1, 2022 which will result in reduced interest expense in future periods. Adoption of the standard resulted in a decrease to accumulated deficit of $17 million, decrease to additional paid-in capital of $19 million and an increase to debt, current of $2 million. Further, we utilized the if-converted method for purposes of diluted net income per share. The impact of the change in methodology to determine diluted net income per share of common stock attributable to common stockholders is immaterial. Recently Issued Accounting Pronouncement Pending Adoption Acquired Contract Assets and Contract Liabilities In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities” which improves comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination by providing consistent recognition guidance. This standard is effective for fiscal years beginning after December 15, 2022. Early adoption is permitted, including in an interim period, for any period for which financial statements have not yet been issued. However, adoption in an interim period other than the first fiscal quarter requires an entity to apply the new guidance to all prior business combinations that have occurred since the beginning of the annual period in which the new guidance is adopted. The Company is currently evaluating the timing of adoption and impact, if any, of this new standard on our consolidated financial statements.

Investments

Investments	3 Months Ended
	Mar. 31, 2022
Debt Securities, Available-for-sale [Abstract]
Investments	Investments Marketable Debt Securities The following is a summary of our available-for-sale debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in millions): March 31, 2022 Amortized Gross Gross Estimated Available-for-sale securities: Commercial paper $ 575 $ — $ (2) $ 573 Corporate notes and bonds 2,424 — (35) 2,389 Certificates of deposit 122 — — 122 U.S. government and agency securities 71 — (1) 70 Mortgage-backed and asset-backed securities 99 — (7) 92 Total available-for-sale securities $ 3,291 $ — $ (45) $ 3,246 December 31, 2021 Amortized Gross Gross Estimated Available-for-sale securities: Commercial paper $ 528 $ — $ — $ 528 Corporate notes and bonds 2,418 1 (7) 2,412 Certificates of deposit 28 — — 28 U.S. government and agency securities 140 — — 140 Mortgage-backed and asset-backed securities 100 — (2) 98 Total available-for-sale securities $ 3,214 $ 1 $ (9) $ 3,206 As of March 31, 2022, the contractual maturities of our available-for-sale debt securities, excluding those securities classified within cash and cash equivalents on the condensed consolidated balance sheet and mortgage-backed and asset-backed securities that do not have a single maturity, did not exceed 36 months. The fair values of available-for-sale securities, by remaining contractual maturity, are as follows (in millions): March 31, 2022 Due within 1 year $ 1,762 Due in 1 year through 5 years 1,392 Instruments not due in single maturity 92 Total $ 3,246 As of March 31, 2022, the fair value of available-for-sale securities in a continuous loss position totaled $3,024 million, the majority of which has been in a continuous unrealized loss position for less than 12 months. The decline in fair value below amortized cost basis was not considered other than temporary as it is more likely than not we will hold the securities until maturity or a recovery of the cost basis, and credit-related impairment losses were not deemed material as of March 31, 2022. Non-Marketable Equity Investments As of March 31, 2022 and December 31, 2021, the total amount of non-marketable equity investments in privately-held companies included in other assets on our condensed consolidated balance sheets was $195 million and $99 million, respectively. Our non-marketable equity investments are accounted for using the measurement alternative which measures the investments at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes resulting from the issuance of similar or identical securities in an orderly transaction by the same issuer. Determining whether an observed transaction is similar to a security within our portfolio requires judgment based on the rights and preferences of the securities. Recording upward and downward adjustments to the carrying value of our equity securities as a result of observable price changes requires quantitative assessments of the fair value of our securities using various valuation methodologies and involves the use of estimates. We classify these fair value measurements as Level 3 within the fair value hierarchy.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of March 31, 2022 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 957 $ — $ 957 Commercial paper — 112 112 Corporate notes and bonds — 7 7 Certificates of deposit — 4 4 Deposits 236 — 236 Marketable securities: Commercial paper — 573 573 Corporate notes and bonds — 2,389 2,389 Certificates of deposit — 122 122 Mortgage-backed and asset-backed securities — 92 92 U.S. government and agency securities — 70 70 Total $ 1,193 $ 3,369 $ 4,562 The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of December 31, 2021 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 706 $ — $ 706 Commercial paper — 110 110 Corporate notes and bonds — 28 28 Certificates of deposit — 8 8 Deposits 235 — 235 Marketable securities: Commercial paper — 528 528 Corporate notes and bonds — 2,412 2,412 Certificates of deposit — 28 28 Mortgage-backed and asset-backed securities — 98 98 U.S. government and agency securities — 140 140 Total $ 941 $ 3,352 $ 4,293 We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) or using unobservable inputs which are supported by little or no market activity (Level 3 inputs). Our non-marketable equity investments are not included in the table above and are discussed in Note 3. See Note 8 for the fair value measurement of our derivative contracts and Note 10 for the fair value measurement of our long-term debt, which are also not included in the table above.

Business Combinations

Business Combinations	3 Months Ended
	Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations On June 15, 2021, we acquired LightStep, Inc., a leading observability solution provider, for $512 million in a cash transaction. The purchase price was preliminarily allocated based on the estimated fair value of developed technology intangible asset of $85 million (five-year estimated useful life), customer-related and brand assets of $11 million, net tangible assets of $8 million, deferred tax liabilities of $6 million and goodwill of $413 million, which is not deductible for income tax purposes. Goodwill is primarily attributed to the value expected from synergies resulting from the business combinations. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions and may be subject to change as additional information is received. The provisional measurements of fair value for income taxes payable and deferred taxes may be subject to change as additional information is received and certain tax returns are finalized. The Company expects to finalize the fair value measurements as soon as practicable, but not later than one year from the acquisition date. We have included the financial results of business combinations in the consolidated financial statements from the respective dates of acquisition, which were not material. Pro forma revenue and earnings amounts on a combined basis have not been presented as it is impracticable due to the lack of availability of historical financial statements that comply with GAAP.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Intangible assets consist of the following (in millions): March 31, 2022 December 31, 2021 Developed technology $ 413 $ 415 Patents 69 69 Other 15 14 Intangible assets, gross 497 498 Less: accumulated amortization (231) (211) Intangible assets, net $ 266 $ 287 The weighted-average useful life for the acquired developed technology for the three months ended March 31, 2022 and 2021 was approximately five years. Amortization expense for intangible assets for the three months ended March 31, 2022 and 2021 was $20 million and $17 million, respectively. The following table presents the estimated future amortization expense related to intangible assets held at March 31, 2022 (in millions): Years Ending December 31, Remainder of 2022 $ 60 2023 74 2024 66 2025 45 2026 15 Thereafter 6 Total future amortization expense $ 266

Property and Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment, net consists of the following (in millions): March 31, 2022 December 31, 2021 Computer equipment $ 1,312 $ 1,226 Computer software 75 77 Leasehold and other improvements 200 200 Furniture and fixtures 76 74 Construction in progress 10 14 Property and equipment, gross 1,673 1,591 Less: Accumulated depreciation (875) (825) Property and equipment, net $ 798 $ 766

Derivative Contracts

Derivative Contracts	3 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Contracts	Derivative Contracts As of March 31, 2022 and December 31, 2021, we had foreign currency forward contracts with total notional values of $443 million and $833 million, respectively, which are not designated as hedging instruments. Our foreign currency forward contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates. The fair value of these outstanding derivative contracts was as follows (in millions): Condensed Consolidated Balance Sheet Location March 31, 2022 December 31, 2021 Derivative Assets: Foreign currency derivative contracts Prepaid expenses and other current assets $ 3 $ 2 Derivative Liabilities: Foreign currency derivative contracts Accrued expenses and other current liabilities $ 4 $ 3

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Revenue and Performance Obligations Revenues recognized during the three months ended March 31, 2022 from amounts included in deferred revenue as of December 31, 2021 were $1.4 billion. Revenues recognized during the three months ended March 31, 2021 from amounts included in deferred revenue as of December 31, 2020 were $1.1 billion. Remaining Performance Obligations Transaction price allocated to remaining performance obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenues in future periods. RPO excludes contracts that are billed in arrears, such as certain time and materials contracts, as we apply the “right to invoice” practical expedient under relevant accounting guidance.

Debt

Debt	3 Months Ended
	Mar. 31, 2022
Convertible Notes Payable [Abstract]
Debt	Debt The following table summarizes the carrying value of our outstanding debt (in millions, except percentages): March 31, 2022 December 31, 2021 2030 Notes 2022 Notes 2030 Notes 2022 Notes Current, net of unamortized debt discount and issuance costs of $0.04 million and $2 million, respectively $ — $ 88 $ — $ 92 Long-term, net of unamortized debt discount and issuance costs of $16 million and $16 million, respectively 1,484 — 1,484 — Total debt $ 1,484 $ 88 $ 1,484 $ 92 We consider the fair value of the 2030 Notes and 2022 Notes at March 31, 2022 to be a Level 2 measurement. The estimated fair value of the 2030 Notes and 2022 Notes at March 31, 2022 and December 31, 2021 is based on the closing trading price per $100 of the 2030 Notes and 2022 Notes as follows (in millions): March 31, 2022 December 31, 2021 2022 Notes $ 371 $ 440 2030 Notes $ 1,276 $ 1,400 2030 Notes In August 2020, we issued 1.40% fixed rate ten-year notes with an aggregate principal amount of $1.5 billion due on September 1, 2030 (the “2030 Notes”). The 2030 Notes were issued at 99.63% of principal and we incurred approximately $13 million for debt issuance costs. The effective interest rate for the 2030 Notes was 1.53% and included interest payable, amortization of debt issuance cost and amortization of debt discount, as applicable. Interest is payable semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2021, and the entire outstanding principal amount is due at maturity on September 1, 2030. The 2030 Notes are unsecured obligations and the indentures governing the 2030 Notes contain customary events of default and covenants that, among others and subject to exceptions, restrict the Company’s ability to incur or guarantee debt secured by liens on specified assets or enter into sale and lease-back transactions with respect to specified properties. 2022 Notes In May and June 2017, we issued an aggregate of $782.5 million of 0% convertible senior notes (the “2022 Notes”), which are due June 1, 2022 unless earlier converted or repurchased in accordance with their terms. The 2022 Notes do not bear interest, and we cannot redeem the 2022 Notes prior to maturity. The 2022 Notes are unsecured obligations and do not contain any financial covenants or restrictions on the payments of dividends, the incurrence of indebtedness or the issuance or repurchase of securities by us or any of our subsidiaries. As described in Note 2, we adopted the new accounting standard for debt with conversion options effective January 1, 2022 using a modified retrospective method, under which financial results reported in prior periods were not adjusted. Prior to the adoption of the new standard, in accounting for the issuance of the 2022 Notes and the related transaction costs, we valued and bifurcated the conversion option from the host debt instrument, referred to as debt discount, and recorded the conversion option of $160 million in equity at issuance. The resulting debt discount and transactions costs allocated to the liability component are amortized to interest expense using the effective interest method over the term of the 2022 Notes. Upon adoption of the new accounting standard on January 1, 2022, we recombined the liability and equity components of the 2022 Notes, including the related issuance costs, assuming the instrument was accounted for as a single liability from inception to the date of adoption. Issuance costs are presented as a deduction from the outstanding principal balance of the 2022 Notes and amortized to interest expense using the effective interest method over the term of the 2022 Notes. As of March 31, 2022, the effective interest rate for the 2022 Notes was 0.267%. Upon conversion of the 2022 Notes, we may choose to pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock upon settlement. We currently intend to settle the principal amount of the 2022 Notes with cash. Convertible Date Initial Conversion Price per Share Initial Conversion Rate per $1,000 Par Value Initial Number of Shares (in millions) 2022 Notes February 1, 2022 $ 134.75 7.42 shares 6 Conversion of the 2022 Notes prior to the Convertible Date . At any time prior to the close of business on the business day immediately preceding February 1, 2022 (“Convertible Date”), holders of the 2022 Notes may convert their 2022 Notes at their option, only if one of the following conditions are met: • during any calendar quarter (and only during such calendar quarter) if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day (in each case, the “Conversion Condition”); or • during the five-business day period after any five-consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of the 2022 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; or • upon the occurrence of specified corporate events. For conversion requests received prior to maturity, the difference between the fair value and the amortized book value is recorded as a gain or loss on early note conversion. Subsequent to adoption of the new accounting standard on January 1, 2022, no gain or loss is recorded on early note conversion. Conversion of the 2022 Notes on or after the Convertible Date. On or after the Convertible Date, a holder may convert all or any portion of its 2022 Notes at any time prior to the close of business on the second scheduled trading day immediately preceding maturity, regardless of the foregoing conditions, and such conversions will settle upon maturity. Upon settlement, we will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election. The conversion price of the 2022 Notes will be subject to adjustment in some events. Holders of the 2022 Notes who convert their 2022 Notes in connection with certain corporate events that constitute a “make-whole fundamental change” are, under certain circumstances, entitled to an increase in the conversion rate. Additionally, in the event of a corporate event that constitutes a “fundamental change,” holders of the 2022 Notes may require us to purchase with cash all or a portion of the 2022 Notes upon the occurrence of a fundamental change, at a purchase price equal to 100% of the principal amount of the 2022 Notes plus any accrued and unpaid special interest, if any. The Conversion Condition for the 2022 Notes was met for all the quarters ended June 30, 2018 through December 31, 2021, except for the quarter ended December 31, 2018. Therefore, our 2022 Notes were convertible at the holders’ option beginning on July 1, 2018 through January 31, 2022, except for the quarter ended March 31, 2019 because the Conversion Condition for the 2022 Notes was not met for the quarter ended December 31, 2018. Any conversion requests received subsequent to January 31, 2022, will be settled on the maturity date, which is June 1, 2022. During the three months ended March 31, 2022, we paid cash to settle $6 million in principal of the 2022 Notes. As a result of the settlements, we also recorded a net reduction to additional paid-in capital of $21 million offset by $21 million benefit from the 2022 Note Hedge (as defined below). Repurchase of 2022 Notes On August 11, 2020, we repurchased $497 million in aggregate principal amount of the 2022 Notes (the “2022 Notes Repurchase”) funded in part by the $1.1 billion proceeds received from the partial unwind of the 2022 Note Hedge (as defined below). The 2022 Notes Repurchase was accounted for as a debt extinguishment in which $493 million and $1.1 billion were allocated to the liability and equity components of the 2022 Notes, respectively. The cash consideration allocated to the liability component was based on the estimated fair value of the liability component utilizing a discount rate assuming a similar liability per the Company’s credit rating with the same maturity, but without the conversion option, as of the repurchase date. The cash consideration allocated to the equity component was based on the aggregate cash consideration less the estimated fair value of the liability component. The loss on extinguishment of $39 million recorded as other income (expense), net, represents the difference between the allocated cash consideration and the carrying value of the liability component, which includes the proportionate amounts of unamortized debt discount and unamortized debt issuance costs in the amount of $43 million. Note Hedge To minimize the impact of potential economic dilution upon conversion of the 2022 Notes, we entered into convertible note hedge transactions (the “2022 Note Hedge”) with certain investment banks, with respect to our common stock concurrently with the issuance of the 2022 Notes. Purchase Initial Shares Shares as of (in millions) 2022 Note Hedge $ 128 6 1 The 2022 Note Hedge covers shares of our common stock at a strike price per share that corresponds to the initial conversion price of the 2022 Notes, subject to adjustment, and are exercisable upon conversion of the 2022 Notes. If exercised, we may elect to receive cash, shares of our common stock, or a combination of cash and shares. The 2022 Note Hedge will expire upon the maturity of the 2022 Notes. The 2022 Note Hedge is intended to reduce the potential economic dilution upon conversion of the 2022 Notes in the event that the fair value per share of our common stock at the time of exercise is greater than the conversion price of the 2022 Notes. The 2022 Note Hedge is a separate transaction and is not part of the terms of the 2022 Notes. Holders of the 2022 Notes will not have any rights with respect to the 2022 Note Hedge. The 2022 Note Hedge does not impact earnings per share, as it was entered into to offset any dilution from the 2022 Notes. On August 11, 2020, in connection with the 2022 Notes Repurchase, we entered into partial unwind agreements (the “Note Hedge Unwind”) to reduce the number of options corresponding to the principal amount of the 2022 Notes Repurchase. We received $1.1 billion for the Note Hedge Unwind and the aggregate number of shares underlying the call options under the 2022 Note Hedge was reduced by 3.7 million shares. Consistent with early conversions of the 2022 Notes, proceeds received by the Company from the Note Hedge Unwind were used to settle a portion of the 2022 Notes Repurchase. Warrants Proceeds Initial Shares Strike Price First Expiration Date Shares as of (in millions) (in millions) (in millions) 2022 Warrants $ 54 6 $ 203.40 September 1, 2022 1 Separately, we entered into warrant transactions with certain investment banks, whereby we sold warrants to acquire, subject to adjustment, the number of shares of our common stock shown in the table above (the “2022 Warrants”). If the average market value per share of our common stock for the reporting period, as measured under the 2022 Warrants, exceeds the strike price of the respective 2022 Warrants, such 2022 Warrants would have a dilutive effect on our earnings per share to the extent we report net income. The 2022 Warrants are separate transactions and are not remeasured through earnings each reporting period. The 2022 Warrants are not part of the 2022 Notes or 2022 Note Hedge. In connection with the 2022 Notes Repurchase and early note conversions, we entered into partial unwind agreements to reduce the number of warrants outstanding under the 2022 Warrants by delivering an aggregate 0.5 million shares of our common stock during the three months ended March 31, 2021. According to the terms, the remaining portion of the 2022 Warrants will be net share settled and automatically exercised over a 60 trading day period beginning on the first expiration date as set forth above based on the daily volume-weighted average stock prices over the same 60 trading day period . We expect to issue additional shares of our common stock in the second half of 2022 upon the automatic exercise of the remaining portion of the 2022 Warrants. The remaining portion of the 2022 Warrants could have a dilutive effect to the extent that the daily volume-weighted average stock prices over a 60 trading day period beginning on September 1, 2022 exceeds the strike price of the 2022 Warrants. Based on the volume-weighted average stock price on March 31, 2022, the total number of shares of our common stock to be issued upon the automatic exercise of the remaining portion of the 2022 Warrants would be approximately 0.6 million. The actual number of shares of our common stock issuable upon the automatic exercise of the remaining portion of the 2022 Warrants, if any, is unknown at this time.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The components of accumulated other comprehensive income (loss), net of tax, consist of the following (in millions): March 31, 2022 December 31, 2021 Foreign currency translation adjustment $ 33 $ 46 Net unrealized losses on investments, net of tax (49) (12) Accumulated other comprehensive income (loss) $ (16) $ 34 Reclassification adjustments out of accumulated other comprehensive income (loss) into net income were not material for all periods presented.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Common Stock We are authorized to issue a total of 600 million shares of common stock as of March 31, 2022. Holders of our common stock are not entitled to receive dividends unless declared by our board of directors. As of March 31, 2022, we had 200.5 million shares of common stock outstanding and had reserved shares of common stock for future issuance as follows (in thousands): March 31, 2022 Stock plans: Options outstanding 1,285 RSUs (1) 7,350 Shares of common stock available for future grants: 2021 Equity Incentive Plan (2) 6,002 Amended and Restated 2012 Employee Stock Purchase Plan (2) 9,179 Total shares of common stock reserved for future issuance 23,816 (1) Represents the number of shares issuable upon settlement of outstanding restricted stock units (“RSUs”) and performance-based RSUs (“PRSUs”), as discussed under Note 13. (2) Refer to Note 13 for a description of these plans. During the three months ended March 31, 2022 and 2021, we issued a total of 0.8 million shares and 1.1 million shares, respectively, from stock option exercises, vesting of RSUs, net of employee payroll taxes and purchases from the employee stock purchase plan (“ESPP”). In addition, as described in Note 10, during the three months ended March 31, 2021, w e issued 0.5 million shares of our common stock upon partial unwind of the 2022 Warrants.

Equity Awards

Equity Awards	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Equity Awards	Equity Awards We currently have three equity incentive plans, our 2005 Stock Option Plan (the “2005 Plan”), 2012 Equity Incentive Plan (the “2012 Plan”) and 2021 Equity Incentive Plan (the “2021 Plan”). The 2005 Plan was terminated in connection with our initial public offering in 2012 but continues to govern the terms of outstanding stock options that were granted prior to the termination of the 2005 Plan. We no longer grant equity awards pursuant to the 2005 Plan. The 2012 Plan was terminated in connection with the approval of the 2021 Plan on June 7, 2021 but continues to govern the terms of outstanding equity awards that were granted prior to the termination of the 2012 Plan. As of June 7, 2021, we no longer grant equity awards pursuant to the 2012 Plan. The 2021 Plan and the 2012 Plan provide for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, RSUs, performance-based stock awards and other forms of equity compensation (collectively, “equity awards”). In addition, the 2021 Plan and the 2012 Plan provide for the grant of performance cash awards. Incentive stock options may be granted only to employees. All other equity awards may be granted to employees, including officers, as well as directors and consultants. Prior to June 7, 2021, the 2012 Plan share reserve was increased to the extent outstanding stock options under the 2005 Plan expire or terminate unexercised. Our Amended and Restated 2012 Employee Stock Purchase Plan (the “2012 ESPP”) authorizes the issuance of shares of common stock pursuant to purchase rights granted to our employees. The price at which common stock is purchased under the 2012 ESPP is equal to 85% of the fair market value of our common stock on the first or last day of the offering period, whichever is lower. Offering periods are six months long and begin on February 1 and August 1 of each year. Prior to June 7, 2021, the number of shares of common stock reserved for issuance automatically increased on January 1 of each year, by up to 1% of the total number of shares of common stock outstanding on December 31 of the preceding year as determined by our board of directors. Our board of directors elected not to increase the number of shares of common stock reserved for issuance under the 2012 ESPP pursuant to the provision described in the preceding sentence for the year ending December 31, 2022, and for the remaining term of the 2012 ESPP, the share reserve will not be increased without shareholder approval. Stock Options Stock options are exercisable at a price equal to the market value of the underlying shares of common stock on the date of the grant as determined by our board of directors or, for those stock options issued subsequent to our initial public offering, the closing price of our common stock as reported on the New York Stock Exchange on the date of grant. Stock options granted under the 2005 Plan and the 2012 Plan to new employees generally vest 25% one year from the date the requisite service period begins and continue to vest monthly for each month of continued employment over the remaining three years. One-time long-term performance-based options granted to the Chief Executive Officer (“2021 CEO Performance Award") and to certain executives (collectively “2021 Performance Awards”) in the fourth quarter of 2021 under the 2021 Plan vest in eight equal tranches based on service conditions and achievement of both performance and market conditions. Options granted generally are exercisable for a period of up to ten years contingent on each holder’s continuous status as a service provider. A summary of stock option activity for the three months ended March 31, 2022 was as follows: Number of Weighted- Weighted- Aggregate (in thousands) (in years) (in millions) Outstanding at December 31, 2021 1,305 $ 551.39 Granted 23 $ 591.66 Exercised (41) $ 24.76 $ 22 Canceled (2) $ 84.80 Outstanding at March 31, 2022 1,285 $ 569.70 8.9 $ 104 Vested and expected to vest as of March 31, 2022 1,036 $ 550.79 8.7 $ 99 Vested and exercisable as of March 31, 2022 150 $ 119.24 4.5 $ 66 Aggregate intrinsic value represents the difference between the estimated fair value of our common stock and the exercise price of outstanding, in-the-money options. The total fair value of stock options vested during the three months ended March 31, 2022 was $3 million. As of March 31, 2022, total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested stock options was approximately $129 million. The weighted-average remaining vesting period of unvested stock options at March 31, 2022 was approximately three years. RSUs A summary of RSU activity for the three months ended March 31, 2022 was as follows: Number of Weighted-Average Grant-Date Fair Value Aggregate (in thousands) (in millions) Outstanding at December 31, 2021 5,808 $ 416.00 Granted 2,612 $ 589.15 Vested (859) $ 339.22 $ 494 Forfeited (211) $ 438.39 Outstanding at March 31, 2022 7,350 $ 486.01 RSUs outstanding as of March 31, 2022 were comprised of 6.8 million RSUs with only service conditions and 0.5 million RSUs with both service and performance conditions, including certain RSUs with additional market conditions. PRSUs with service, performance and market vesting criteria are considered as eligible to vest when approved by the compensation committee of our board of directors in January of the year following the grant. The ultimate number of shares eligible to vest for PRSUs range from 0% to 200% of the target number of shares depending on achievement relative to the performance metrics and, for certain PRSUs, depend on our total shareholder return relative to that of the S&P 500 index over the applicable measurement period. The eligible shares subject to PRSUs granted during the three months ended March 31, 2022 will vest in February of the following year and semi-annually for the remaining two As of March 31, 2022, total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested RSUs was approximately $2.7 billion and the weighted-average remaining vesting period was approximately three years.

Net Income Per Share

Net Income Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net Income Per Share	Net Income Per Share Basic net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, adjusted for the effects of dilutive shares of common stock, which are comprised of outstanding stock options, RSUs, ESPP obligations, the 2022 Notes and the 2022 Warrants. Stock awards with performance or market conditions are included in dilutive shares to the extent all conditions are met. The dilutive potential shares of common stock are computed using the treasury stock method or the as-if converted method, as applicable. The effects of outstanding stock options, RSUs, ESPP obligations, 2022 Notes and 2022 Warrants are excluded from the computation of diluted net income per share in periods in which the effect would be antidilutive. The following tables present the calculation of basic and diluted net income per share attributable to common stockholders (in thousands, except per share data): Three Months Ended March 31, 2022 2021 Numerator: Net income $ 75,350 $ 82,440 Denominator: Weighted-average shares outstanding - basic 200,088 196,624 Weighted-average effect of potentially dilutive securities: Common stock options 180 351 RSUs 1,892 3,671 2022 Notes — 748 2022 Notes settlements — 50 2022 Warrants 640 618 Partial settlement of 2022 Warrants — 206 Weighted-average shares outstanding - diluted 202,800 202,268 Net income per share - basic $ 0.38 $ 0.42 Net income per share - diluted $ 0.37 $ 0.41 Potentially dilutive securities that are not included in the calculation of diluted net income per share because doing so would be antidilutive are as follows (in thousands): Three Months Ended March 31, 2022 2021 Common stock options 1,022 36 RSUs 3,766 1,748 ESPP obligations 159 144 2022 Convertible senior notes 689 — Total potentially dilutive securities 5,636 1,928

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjust the provision for discrete tax items recorded in the period. Our income tax provision was $10 million for the three months ended March 31, 2022. The income tax provision was primarily attributable to the mix of earnings and losses in countries with differing statutory tax rates and the valuation allowance in the United States. Our income tax provision was $17 million for the three months ended March 31, 2021. The income tax provision was primarily attributable to the mix of earnings and losses in countries with differing statutory tax rates and the valuation allowance in the United States. We are subject to taxation in the United States and foreign jurisdictions. As of March 31, 2022, our tax years 2004 to 2021 remain subject to examination in most jurisdictions.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Operating Leases For some of our offices and data centers, we have entered into non-cancelable operating lease agreements with various expiration dates through 2035. Certain lease agreements include options to renew or terminate the lease, which are not reasonably certain to be exercised and therefore are not factored into our determination of lease payments. Total operating lease costs were $27 million and $22 million, excluding short-term lease costs, variable lease costs and sublease income, each of which were immaterial, for the three months ended March 31, 2022 and 2021, respectively. For the three months ended March 31, 2022 and 2021, cash paid for amounts included in the measurement of operating lease liabilities was $19 million and $18 million, respectively. Operating lease liabilities arising from obtaining operating right-of-use assets totaled $15 million and $21 million for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, the weighted-average remaining lease term is approximately nine years, and the weighted-average discount rate is 3%. Maturities of operating lease liabilities as of March 31, 2022 are presented in the table below (in millions): Remainder of 2022 $ 78 2023 105 2024 88 2025 77 2026 58 Thereafter 327 Total operating lease payments 733 Less: imputed interest (99) Present value of operating lease liabilities $ 634 In addition to the amounts above, as of March 31, 2022, we have operating leases, primarily for offices, that have not yet commenced with undiscounted cash flows of $208 million. These operating leases will commence in 2022 with lease terms of 4 years to 13 years. Other Commitments Other contractual commitments consist of data center and IT operations and sales and marketing activities. There were no material contractual obligations that were entered into during the three months ended March 31, 2022 that were outside the ordinary course of business. In addition to the amounts above, the repayment of our 2022 Notes and 2030 Notes with an aggregate principal amount of $88 million and $1.5 billion is due on June 1, 2022 and September 1, 2030, respectively. Refer to Note 10 for further information regarding our Notes. Further, $35 million of unrecognized tax benefits have been recorded as liabilities as of March 31, 2022. Legal Proceedings From time to time, we are party to litigation and other legal proceedings in the ordinary course of business. While the results of any litigation or other legal proceedings are uncertain, management does not believe the ultimate resolution of any pending legal matters is likely to have a material adverse effect on our financial position, results of operations or cash flows, except for those matters for which we have recorded a loss contingency. We accrue for loss contingencies when it is both probable that we will incur the loss and when we can reasonably estimate the amount of the loss or range of loss. Generally, our subscription agreements require us to defend our customers for third-party intellectual property infringement and other claims. Any adverse determination related to intellectual property claims or other litigation could prevent us from offering our services and adversely affect our financial condition and results of operations. Indemnification Provisions Our agreements include provisions indemnifying customers against intellectual property and other third-party claims. In addition, we have entered into indemnification agreements with our directors, executive officers and certain other officers that will require us, among other things, to indemnify them against certain liabilities that may arise as a result of their affiliation with us. We have not incurred any costs as a result of such indemnification obligations and have not recorded any liabilities related to such obligations in the condensed consolidated financial statements.

Information about Geographic Ar

Information about Geographic Areas and Products	3 Months Ended
	Mar. 31, 2022
Segments, Geographical Areas [Abstract]
Information about Geographic Areas and Products	Information about Geographic Areas and Products Revenues by geographic area, based on the location of our users, were as follows for the periods presented (in millions): Three Months Ended March 31, 2022 2021 North America (1) $ 1,116 $ 883 EMEA (2) 434 343 Asia Pacific and other 172 134 Total revenues $ 1,722 $ 1,360 Property and equipment, net by geographic area were as follows (in millions): March 31, 2022 December 31, 2021 North America (3) $ 491 $ 484 EMEA (2) 191 176 Asia Pacific and other 116 106 Total property and equipment, net $ 798 $ 766 (1) Revenues attributed to the United States were 94% of North America revenues for the three months ended March 31, 2022 and 2021, respectively. (2) Europe, the Middle East and Africa (“EMEA”) (3) Property and equipment, net attributed to the United States were approximately 82% and 84% of property and equipment, net attributable to North America as of March 31, 2022 and December 31, 2021, respectively. Subscription revenues consist of the following (in millions): Three Months Ended March 31, 2022 2021 Digital workflow products $ 1,440 $ 1,131 ITOM products 191 162 Total subscription revenues $ 1,631 $ 1,293

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsXXX

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and condensed footnotes have been prepared in accordance with the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements due to the permitted exclusion of certain disclosures for interim reporting. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary under GAAP for fair statement of results for the interim periods presented have been included. As a result of displaying amounts in millions, rounding differences may exist in the consolidated financial statements and footnote tables. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for other interim periods or future years. The condensed consolidated balance sheet as of December 31, 2021 is derived from audited consolidated financial statements; however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 3, 2022.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, and include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenues and expenses during the reporting period. Such management estimates and assumptions include, but are not limited to, standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations, the period of benefit for deferred commissions, valuation of intangible assets, the useful life of property and equipment and identifiable intangible assets, stock-based compensation expense and income taxes. Actual results could differ from those estimates. We assessed the impact of COVID-19 on the estimates and assumptions and determined there was no material impact.
Concentration of Credit Risk and Significant Customers	Concentration of Credit Risk and Significant CustomersCredit risk arising from accounts receivable is mitigated to a certain extent due to our large number of customers and their dispersion across various industries and geographies. As of March 31, 2022, we had one customer, a channel partner, that represented 10% of our accounts receivable. As of December 31, 2021, there were no customers that represented more than 10% of our accounts receivable balance. Further, there were no customers that individually exceeded 10% of our total revenues in any of the periods presented. Our customers in Russia represented an immaterial portion of our total consolidated revenues and our accounts receivable balance in any of the periods presented. For purposes of assessing concentration of credit risk and significant customers, a group of customers under common control or customers that are affiliates of each other are regarded as a single customer.
Recently Adopted Accounting Pronouncement and Recently Issued Accounting Pronouncement Pending Adoption	Recently Adopted Accounting Pronouncement Debt with Conversion Options In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, “Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40)” to simplify the accounting for convertible instruments and contracts on an entity’s own equity. The standard results in our 2022 Notes being accounted for as a single unit of debt and requires the if-converted method to calculate diluted earnings per share calculation. We adopted this standard effective January 1, 2022 using a modified retrospective method, under which the basis of all convertible instruments outstanding at adoption have been adjusted to the amounts that would have been recorded had the new guidance been applied from inception. The previously recorded equity component of the convertible instrument outstanding and amortization of the debt discount and issuance costs classified as equity are reclassified from equity to debt through an adjustment to the opening balance of accumulated deficit as of January 1, 2022 which will result in reduced interest expense in future periods. Adoption of the standard resulted in a decrease to accumulated deficit of $17 million, decrease to additional paid-in capital of $19 million and an increase to debt, current of $2 million. Further, we utilized the if-converted method for purposes of diluted net income per share. The impact of the change in methodology to determine diluted net income per share of common stock attributable to common stockholders is immaterial. Recently Issued Accounting Pronouncement Pending Adoption Acquired Contract Assets and Contract Liabilities In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities” which improves comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination by providing consistent recognition guidance. This standard is effective for fiscal years beginning after December 15, 2022. Early adoption is permitted, including in an interim period, for any period for which financial statements have not yet been issued. However, adoption in an interim period other than the first fiscal quarter requires an entity to apply the new guidance to all prior business combinations that have occurred since the beginning of the annual period in which the new guidance is adopted. The Company is currently evaluating the timing of adoption and impact, if any, of this new standard on our consolidated financial statements.
Fair Value Measurements	We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) or using unobservable inputs which are supported by little or no market activity (Level 3 inputs).
Legal Proceedings	Legal Proceedings From time to time, we are party to litigation and other legal proceedings in the ordinary course of business. While the results of any litigation or other legal proceedings are uncertain, management does not believe the ultimate resolution of any pending legal matters is likely to have a material adverse effect on our financial position, results of operations or cash flows, except for those matters for which we have recorded a loss contingency. We accrue for loss contingencies when it is both probable that we will incur the loss and when we can reasonably estimate the amount of the loss or range of loss. Generally, our subscription agreements require us to defend our customers for third-party intellectual property infringement and other claims. Any adverse determination related to intellectual property claims or other litigation could prevent us from offering our services and adversely affect our financial condition and results of operations. Indemnification Provisions Our agreements include provisions indemnifying customers against intellectual property and other third-party claims. In addition, we have entered into indemnification agreements with our directors, executive officers and certain other officers that will require us, among other things, to indemnify them against certain liabilities that may arise as a result of their affiliation with us. We have not incurred any costs as a result of such indemnification obligations and have not recorded any liabilities related to such obligations in the condensed consolidated financial statements.

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Securities, Available-for-sale [Abstract]
Schedule of Marketable Debt Securities	The following is a summary of our available-for-sale debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in millions): March 31, 2022 Amortized Gross Gross Estimated Available-for-sale securities: Commercial paper $ 575 $ — $ (2) $ 573 Corporate notes and bonds 2,424 — (35) 2,389 Certificates of deposit 122 — — 122 U.S. government and agency securities 71 — (1) 70 Mortgage-backed and asset-backed securities 99 — (7) 92 Total available-for-sale securities $ 3,291 $ — $ (45) $ 3,246 December 31, 2021 Amortized Gross Gross Estimated Available-for-sale securities: Commercial paper $ 528 $ — $ — $ 528 Corporate notes and bonds 2,418 1 (7) 2,412 Certificates of deposit 28 — — 28 U.S. government and agency securities 140 — — 140 Mortgage-backed and asset-backed securities 100 — (2) 98 Total available-for-sale securities $ 3,214 $ 1 $ (9) $ 3,206
Investments Classified by Contractual Maturity Date	The fair values of available-for-sale securities, by remaining contractual maturity, are as follows (in millions): March 31, 2022 Due within 1 year $ 1,762 Due in 1 year through 5 years 1,392 Instruments not due in single maturity 92 Total $ 3,246

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Assets Measured at Fair Value on Recurring Basis	The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of March 31, 2022 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 957 $ — $ 957 Commercial paper — 112 112 Corporate notes and bonds — 7 7 Certificates of deposit — 4 4 Deposits 236 — 236 Marketable securities: Commercial paper — 573 573 Corporate notes and bonds — 2,389 2,389 Certificates of deposit — 122 122 Mortgage-backed and asset-backed securities — 92 92 U.S. government and agency securities — 70 70 Total $ 1,193 $ 3,369 $ 4,562 The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of December 31, 2021 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 706 $ — $ 706 Commercial paper — 110 110 Corporate notes and bonds — 28 28 Certificates of deposit — 8 8 Deposits 235 — 235 Marketable securities: Commercial paper — 528 528 Corporate notes and bonds — 2,412 2,412 Certificates of deposit — 28 28 Mortgage-backed and asset-backed securities — 98 98 U.S. government and agency securities — 140 140 Total $ 941 $ 3,352 $ 4,293

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following (in millions): March 31, 2022 December 31, 2021 Developed technology $ 413 $ 415 Patents 69 69 Other 15 14 Intangible assets, gross 497 498 Less: accumulated amortization (231) (211) Intangible assets, net $ 266 $ 287
Schedule of Estimated Future Amortization Expense Related to Intangible Assets	The following table presents the estimated future amortization expense related to intangible assets held at March 31, 2022 (in millions): Years Ending December 31, Remainder of 2022 $ 60 2023 74 2024 66 2025 45 2026 15 Thereafter 6 Total future amortization expense $ 266

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment, Net	Property and equipment, net consists of the following (in millions): March 31, 2022 December 31, 2021 Computer equipment $ 1,312 $ 1,226 Computer software 75 77 Leasehold and other improvements 200 200 Furniture and fixtures 76 74 Construction in progress 10 14 Property and equipment, gross 1,673 1,591 Less: Accumulated depreciation (875) (825) Property and equipment, net $ 798 $ 766

Derivative Contracts (Tables)

Derivative Contracts (Tables)	3 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Outstanding Derivative Contracts	The fair value of these outstanding derivative contracts was as follows (in millions): Condensed Consolidated Balance Sheet Location March 31, 2022 December 31, 2021 Derivative Assets: Foreign currency derivative contracts Prepaid expenses and other current assets $ 3 $ 2 Derivative Liabilities: Foreign currency derivative contracts Accrued expenses and other current liabilities $ 4 $ 3

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2022
Convertible Notes Payable [Abstract]
Summary of Convertible Senior Notes	The following table summarizes the carrying value of our outstanding debt (in millions, except percentages): March 31, 2022 December 31, 2021 2030 Notes 2022 Notes 2030 Notes 2022 Notes Current, net of unamortized debt discount and issuance costs of $0.04 million and $2 million, respectively $ — $ 88 $ — $ 92 Long-term, net of unamortized debt discount and issuance costs of $16 million and $16 million, respectively 1,484 — 1,484 — Total debt $ 1,484 $ 88 $ 1,484 $ 92 Convertible Date Initial Conversion Price per Share Initial Conversion Rate per $1,000 Par Value Initial Number of Shares (in millions) 2022 Notes February 1, 2022 $ 134.75 7.42 shares 6
Schedule of Estimated Fair Values of Convertible Senior Notes	The estimated fair value of the 2030 Notes and 2022 Notes at March 31, 2022 and December 31, 2021 is based on the closing trading price per $100 of the 2030 Notes and 2022 Notes as follows (in millions): March 31, 2022 December 31, 2021 2022 Notes $ 371 $ 440 2030 Notes $ 1,276 $ 1,400
Schedule of Note Hedges	Purchase Initial Shares Shares as of (in millions) 2022 Note Hedge $ 128 6 1
Schedule of Warrants	Proceeds Initial Shares Strike Price First Expiration Date Shares as of (in millions) (in millions) (in millions) 2022 Warrants $ 54 6 $ 203.40 September 1, 2022 1

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income, Net of Tax	The components of accumulated other comprehensive income (loss), net of tax, consist of the following (in millions): March 31, 2022 December 31, 2021 Foreign currency translation adjustment $ 33 $ 46 Net unrealized losses on investments, net of tax (49) (12) Accumulated other comprehensive income (loss) $ (16) $ 34

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of Common Stock Outstanding and Reserved Shares of Common Stock for Future Issuance	As of March 31, 2022, we had 200.5 million shares of common stock outstanding and had reserved shares of common stock for future issuance as follows (in thousands): March 31, 2022 Stock plans: Options outstanding 1,285 RSUs (1) 7,350 Shares of common stock available for future grants: 2021 Equity Incentive Plan (2) 6,002 Amended and Restated 2012 Employee Stock Purchase Plan (2) 9,179 Total shares of common stock reserved for future issuance 23,816 (1) Represents the number of shares issuable upon settlement of outstanding restricted stock units (“RSUs”) and performance-based RSUs (“PRSUs”), as discussed under Note 13. (2) Refer to Note 13 for a description of these plans.

Equity Awards (Tables)

Equity Awards (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	A summary of stock option activity for the three months ended March 31, 2022 was as follows: Number of Weighted- Weighted- Aggregate (in thousands) (in years) (in millions) Outstanding at December 31, 2021 1,305 $ 551.39 Granted 23 $ 591.66 Exercised (41) $ 24.76 $ 22 Canceled (2) $ 84.80 Outstanding at March 31, 2022 1,285 $ 569.70 8.9 $ 104 Vested and expected to vest as of March 31, 2022 1,036 $ 550.79 8.7 $ 99 Vested and exercisable as of March 31, 2022 150 $ 119.24 4.5 $ 66
Schedule of Restricted Stock Unit Activity	A summary of RSU activity for the three months ended March 31, 2022 was as follows: Number of Weighted-Average Grant-Date Fair Value Aggregate (in thousands) (in millions) Outstanding at December 31, 2021 5,808 $ 416.00 Granted 2,612 $ 589.15 Vested (859) $ 339.22 $ 494 Forfeited (211) $ 438.39 Outstanding at March 31, 2022 7,350 $ 486.01

Net Income Per Share (Tables)

Net Income Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Income Per Share	The following tables present the calculation of basic and diluted net income per share attributable to common stockholders (in thousands, except per share data): Three Months Ended March 31, 2022 2021 Numerator: Net income $ 75,350 $ 82,440 Denominator: Weighted-average shares outstanding - basic 200,088 196,624 Weighted-average effect of potentially dilutive securities: Common stock options 180 351 RSUs 1,892 3,671 2022 Notes — 748 2022 Notes settlements — 50 2022 Warrants 640 618 Partial settlement of 2022 Warrants — 206 Weighted-average shares outstanding - diluted 202,800 202,268 Net income per share - basic $ 0.38 $ 0.42 Net income per share - diluted $ 0.37 $ 0.41
Schedule of Potentially Dilutive Securities	Potentially dilutive securities that are not included in the calculation of diluted net income per share because doing so would be antidilutive are as follows (in thousands): Three Months Ended March 31, 2022 2021 Common stock options 1,022 36 RSUs 3,766 1,748 ESPP obligations 159 144 2022 Convertible senior notes 689 — Total potentially dilutive securities 5,636 1,928

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of March 31, 2022 are presented in the table below (in millions): Remainder of 2022 $ 78 2023 105 2024 88 2025 77 2026 58 Thereafter 327 Total operating lease payments 733 Less: imputed interest (99) Present value of operating lease liabilities $ 634

Information about Geographic _2

Information about Geographic Areas and Products (Tables)	3 Months Ended
	Mar. 31, 2022
Segments, Geographical Areas [Abstract]
Revenues by Geographic Area, Based on Billing Location of Customer	Revenues by geographic area, based on the location of our users, were as follows for the periods presented (in millions): Three Months Ended March 31, 2022 2021 North America (1) $ 1,116 $ 883 EMEA (2) 434 343 Asia Pacific and other 172 134 Total revenues $ 1,722 $ 1,360
Schedule of Long Lived Assets by Geographic Area	Property and equipment, net by geographic area were as follows (in millions): March 31, 2022 December 31, 2021 North America (3) $ 491 $ 484 EMEA (2) 191 176 Asia Pacific and other 116 106 Total property and equipment, net $ 798 $ 766 (1) Revenues attributed to the United States were 94% of North America revenues for the three months ended March 31, 2022 and 2021, respectively. (2) Europe, the Middle East and Africa (“EMEA”) (3) Property and equipment, net attributed to the United States were approximately 82% and 84% of property and equipment, net attributable to North America as of March 31, 2022 and December 31, 2021, respectively.
Schedule of Subscription Revenue	Subscription revenues consist of the following (in millions): Three Months Ended March 31, 2022 2021 Digital workflow products $ 1,440 $ 1,131 ITOM products 191 162 Total subscription revenues $ 1,631 $ 1,293

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Jan. 31, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Jan. 01, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Depreciation		$ 58,000	$ 71,000
Net income		$ 75,350	$ 82,440
Net income per share - basic (in USD per share)		$ 0.38	$ 0.42
Net income per share - diluted (in USD per share)		$ 0.37	$ 0.41
Decrease in accumulated deficit		$ (88,000)		$ 4,000
Increase to debt, current		$ 88,000		$ 92,000
Channel Partner | Accounts Receivable | Customer Concentration Risk
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk		10.00%
Accounting Standards Update 2020-06
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in accumulated deficit					$ 17,000
Decrease in additional paid in capital					19,000
Increase to debt, current					$ 2,000
Service Life | Data Center Equipment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Property and equipment, useful life (in years)	4 years			3 years
Depreciation		$ 21,000
Net income		$ 20,000
Net income per share - basic (in USD per share)		$ 0.10
Net income per share - diluted (in USD per share)		$ 0.10

Investments - Summary of Invest

Investments - Summary of Investments (Detail) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 3,291	$ 3,214
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(45)	(9)
Estimated Fair Value	3,246	3,206
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	575	528
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(2)	0
Estimated Fair Value	573	528
Corporate notes and bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,424	2,418
Gross Unrealized Gains	0	1
Gross Unrealized Losses	(35)	(7)
Estimated Fair Value	2,389	2,412
Certificates of deposit
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	122	28
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	122	28
U.S. government and agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	71	140
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1)	0
Estimated Fair Value	70	140
Mortgage-backed and asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	99	100
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(7)	(2)
Estimated Fair Value	$ 92	$ 98

Investments - Narrative (Detail

Investments - Narrative (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Abstract]
Contractual maturities	36 months
Continuous unrealized loss position, fair value	$ 3,024
Non-marketable equity investment	$ 195	$ 99
Celonis SE
Debt Securities, Available-for-sale [Line Items]
Non-marketable equity investment		$ 100

Investments - Maturities of Ava

Investments - Maturities of Available-for-Sale Investments (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Abstract]
Due within 1 year	$ 1,762
Due in 1 year through 5 years	1,392
Instruments not due in single maturity	92
Total	$ 3,246	$ 3,206

Fair Value Measurements (Detail

Fair Value Measurements (Detail) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 4,562	$ 4,293
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	1,193	941
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	3,369	3,352
Cash equivalents | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	957	706
Cash equivalents | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	112	110
Cash equivalents | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	7	28
Cash equivalents | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	4	8
Cash equivalents | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	236	235
Cash equivalents | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	957	706
Cash equivalents | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Cash equivalents | Level 1 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Cash equivalents | Level 1 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Cash equivalents | Level 1 | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	236	235
Cash equivalents | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Cash equivalents | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	112	110
Cash equivalents | Level 2 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	7	28
Cash equivalents | Level 2 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	4	8
Cash equivalents | Level 2 | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Investments | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	573	528
Investments | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,389	2,412
Investments | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	122	28
Investments | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	92	98
Investments | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	70	140
Investments | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Investments | Level 1 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Investments | Level 1 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Investments | Level 1 | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Investments | Level 1 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Investments | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	573	528
Investments | Level 2 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,389	2,412
Investments | Level 2 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	122	28
Investments | Level 2 | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	92	98
Investments | Level 2 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 70	$ 140

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Millions	Jun. 15, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 774		$ 777
LightStep Inc.
Business Acquisition [Line Items]
Cash payment to acquire businesses	$ 512
Net tangible assets	8
Deferred tax liabilities	6
Goodwill	413
Developed technology
Business Acquisition [Line Items]
Weighted average useful life		5 years	5 years
Developed technology | LightStep Inc.
Business Acquisition [Line Items]
Intangible assets	$ 85
Weighted average useful life	5 years
Customer-related and brand assets | LightStep Inc.
Business Acquisition [Line Items]
Intangible assets	$ 11

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 497	$ 498
Less: accumulated amortization	(231)	(211)
Intangible assets, net	266	287
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	413	415
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	69	69
Intangible assets, net	266	287
Other
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 15	$ 14

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 20	$ 17
Developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	5 years	5 years

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Estimated Future Amortization of Intangible Assets (Details) $ in Millions	Mar. 31, 2022USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2022	$ 60
2023	74
2024	66
2025	45
2026	15
Thereafter	6
Total future amortization expense	$ 266

Property and Equipment (Detail)

Property and Equipment (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,673		$ 1,591
Less: Accumulated depreciation	(875)		(825)
Property and equipment, net	798		766
Depreciation	58	$ 71
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,312		1,226
Computer software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	75		77
Leasehold and other improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	200		200
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	76		74
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 10		$ 14

Derivative Contracts (Details)

Derivative Contracts (Details) - Foreign currency derivative contracts - Not Designated as Hedging Instruments - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Derivative, notional amount	$ 443	$ 833
Level 2 | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative Assets	3	2
Level 2 | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities	$ 4	$ 3

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations - Revenues Recognized from Deferred Revenues (Details) - USD ($) $ in Billions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 1.4	$ 1.1

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations - Transaction Price Allocated to the Remaining Performance Obligations (Details) $ in Billions	Mar. 31, 2022USD ($)
Revenue from Contract with Customer [Abstract]
Remaining non-cancelable performance obligations	$ 11.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied (percent)	50.00%
Performance obligations period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied (percent)	50.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations period	2 years

Debt - Schedule of Notes Payabl

Debt - Schedule of Notes Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Current, net of unamortized debt discount and issuance costs of $0.04 million and $2 million, respectively	$ 88,000	$ 92,000
2030 Notes
Debt Instrument [Line Items]
Current, net of unamortized debt discount and issuance costs of $0.04 million and $2 million, respectively	0	0
Long-term, net of unamortized debt discount and issuance costs of $16 million and $16 million, respectively	1,484,000	1,484,000
Total debt	1,484,000	1,484,000
Unamortized debt discount and issuance costs, long-term	16,000	16,000
2022 Notes
Debt Instrument [Line Items]
Current, net of unamortized debt discount and issuance costs of $0.04 million and $2 million, respectively	88,000	92,000
Long-term, net of unamortized debt discount and issuance costs of $16 million and $16 million, respectively	0	0
Total debt	88,000	92,000
Unamortized debt discount and issuance costs, current	$ 40	$ 2,000

Debt - Narrative (Details)

Debt - Narrative (Details) $ / shares in Units, shares in Millions	Aug. 11, 2020USD ($)shares	Aug. 31, 2020USD ($)	Mar. 31, 2022USD ($)day$ / sharesshares	Mar. 31, 2021USD ($)shares	Dec. 31, 2021$ / shares	Jun. 30, 2017USD ($)
Debt Instrument [Line Items]
Estimated fair value of the note based on the closing trading price (in USD per share) | $ / shares			$ 100		$ 100
Percentage of purchase price of notes which should be paid upon fundamental change (percent)			100.00%
Benefit from exercise of 2022 Note Hedge			$ 21,000,000	$ 102,000,000
2022 Warrants
Debt Instrument [Line Items]
Number of shares to be issued upon exercise of the Warrants (in shares) | shares				0.5
Warrant exercise period			60 days
Number of potential securities issued upon automatic exercise of the Warrants (in shares) | shares			0.6
Stock Price Trigger Measurement
Debt Instrument [Line Items]
Trading days threshold | day			20
Consecutive trading days threshold, total | day			30
Threshold percentage of stock price trigger (percent)			130.00%
Notes Price Trigger Measurement
Debt Instrument [Line Items]
Trading days threshold | day			5
Consecutive trading days threshold, total | day			5
Threshold percentage of stock price trigger (percent)			98.00%
Conversion of notes base conversion price			$ 1,000
2030 Notes
Debt Instrument [Line Items]
Contractual interest rate, notes		1.40%
Debt term		10 years
Face amount of debt		$ 1,500,000,000	$ 1,500,000,000
Percentage of principle issued		0.9963
Payments of debt issuance costs		$ 13,000,000
Effective interest rate			1.53%
2022 Notes
Debt Instrument [Line Items]
Contractual interest rate, notes			0.267%			0.00%
Face amount of debt			$ 88,000,000			$ 782,500,000
Equity recorded at time of issuance			160,000,000
Cash paid for settlement of debt			6,000,000
Fair value adjustments			(21,000,000)
Benefit from exercise of 2022 Note Hedge			$ 21,000,000
Repurchased face amount	$ 497,000,000
Net proceeds from unwind of 2022 Note Hedge	1,100,000,000
Extinguishment of debt, amount, debt component	493,000,000
Extinguishment of debt, amount, equity component	1,100,000,000
Unamortized debt discount and unamortized debt issuance costs	$ 43,000,000
Reduction of aggregate number of call options (in shares) | shares	3.7
Loss on extinguishment of debt	$ 39,000,000

Debt - Schedule of Fair Value (

Debt - Schedule of Fair Value (Details) - Level 2 - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
2022 Notes
Debt Instrument [Line Items]
Estimated fair values of notes	$ 371	$ 440
2030 Notes
Debt Instrument [Line Items]
Estimated fair values of notes	$ 1,276	$ 1,400

Debt - Schedule of Conversion (

Debt - Schedule of Conversion (Details) - 2022 Notes shares in Millions	2 Months Ended
	Jun. 30, 2017shares$ / shares
Debt Instrument [Line Items]
Initial Conversion Price per Share (in USD per share) | $ / shares	$ 134.75
Initial Conversion Rate	0.00742
Initial Number of Shares (in shares) | shares	6

Debt - Schedule of Note Hedges

Debt - Schedule of Note Hedges (Details) - 2022 Note Hedge shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)shares
Derivative [Line Items]
Purchase | $	$ 128
Initial Shares (in shares)	6
Shares (in shares)	1

Debt - Schedule of Warrants (De

Debt - Schedule of Warrants (Details) - 2022 Warrants $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Class of Warrant or Right [Line Items]
Proceeds | $	$ 54
Initial Shares (in shares)	6
Strike Price (in USD per share) | $ / shares	$ 203.40
Shares (in shares)	1

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	$ 3,997	$ 3,695	$ 3,037	$ 2,834
Foreign currency translation adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	33	46
Net unrealized losses on investments, net of tax
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(49)	(12)
Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	$ (16)	$ 34	$ 56	$ 94

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Detail) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Class of Stock [Line Items]
Shares of common stock, authorized (in shares)	600,000,000
Shares of common stock, issued and sold (in shares)	200,500,000
Stock issued during period, shares, new issues (in shares)	800,000	1,100,000
2022 convertible senior notes
Class of Stock [Line Items]
Number of shares to be issued upon exercise of the Warrants (in shares)		500,000

Stockholders' Equity - Outstand

Stockholders' Equity - Outstanding and Reserved Shares of Common Stock for Future Issuance (Detail) - shares shares in Thousands	Mar. 31, 2022	Dec. 31, 2021
Stock plans:
Options outstanding (in shares)	1,285	1,305
Total shares of common stock reserved for future issuance (in shares)	23,816
2021 Equity Incentive Plan
Stock plans:
Total shares of common stock reserved for future issuance (in shares)	6,002
Amended and Restated 2012 Employee Stock Purchase Plan
Stock plans:
Total shares of common stock reserved for future issuance (in shares)	9,179
Options outstanding
Stock plans:
Options outstanding (in shares)	1,285
ESPP obligations
Stock plans:
RSUs (in shares)	7,350	5,808

Equity Awards - Narrative (Deta

Equity Awards - Narrative (Detail) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)trancheplanshares	Mar. 31, 2021USD ($)	Dec. 31, 2021shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | plan	3
Fair value of stock options vested	$ 3
Total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested stock options	$ 129
Common stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining weighted-average period	3 years
Restricted stock units with service condition only
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding (in shares) | shares	6,800
Restricted stock units with service and performance conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding (in shares) | shares	500
Performance-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)	100.00%
Stock-based compensation expense, net of actual and estimated forfeitures	$ 29	$ 24
Performance-based RSUs | Vesting, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term	2 years
Performance-based RSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)	0.00%
Performance-based RSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)	200.00%
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining weighted-average period	3 years
Number of shares outstanding (in shares) | shares	7,350		5,808
Unrecognized compensation expense expected to be recognized	$ 2,700
2012 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock purchase price percentage	85.00%
Award offering period	6 months
Number of shares of common stock outstanding, increase, percentage	1.00%
2005 and 2012 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted to new employees vest, percentage per annum	25.00%
Requisite service period to vest employment continuation period	3 years
Number of vesting tranches | tranche	8
Options granted, exercisable period	10 years
2021 Performance Awards | Common stock options | Vesting, tranche one | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Vesting, tranche two | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Vesting, tranche three | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Vesting, tranche four | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Vesting, tranche five | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Vesting, tranche six | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Vesting, tranche seven | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%
2021 Performance Awards | Common stock options | Vesting, tranche eight | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	12.50%

Equity Awards - Summary of Stoc

Equity Awards - Summary of Stock Option Activity (Detail) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Number of Shares
Outstanding, beginning balance (in shares) | shares	1,305
Granted (in shares) | shares	23
Exercised (in shares) | shares	(41)
Canceled (in shares) | shares	(2)
Outstanding, ending balance (in shares) | shares	1,285
Vested and expected to vest (in shares) | shares	1,036
Vested and exercisable (in shares) | shares	150
Weighted- Average Exercise Price Per Share
Outstanding, beginning balance (in USD per share) | $ / shares	$ 551.39
Granted (in USD per share) | $ / shares	591.66
Exercised (in USD per share) | $ / shares	24.76
Canceled (in dollars per share) | $ / shares	84.80
Outstanding, ending balance (in USD per share) | $ / shares	569.70
Vested and expected to vest (in USD per share) | $ / shares	550.79
Vested and exercisable (in USD per share) | $ / shares	$ 119.24
Weighted-average remaining contractual term, outstanding	8 years 10 months 24 days
Weighted-average remaining contractual term, vested and expected to vest	8 years 8 months 12 days
Weighted-average remaining contractual term, vested and exercisable	4 years 6 months
Aggregate intrinsic value, exercised | $	$ 22
Aggregate intrinsic value, outstanding | $	104
Aggregate intrinsic value, vested and expected to vest | $	99
Aggregate intrinsic value, vested and exercisable | $	$ 66

Equity Awards - Restricted Stoc

Equity Awards - Restricted Stock Unit Table (Details) - RSUs $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Number of Shares
Outstanding, beginning balance (in shares) | shares	5,808
Granted (in shares) | shares	2,612
Vested (in shares) | shares	(859)
Forfeited (in shares) | shares	(211)
Outstanding, ending balance (in shares) | shares	7,350
Weighted-Average Grant-Date Fair Value Per Share
Outstanding, beginning balance (in USD per share) | $ / shares	$ 416
Granted (in USD per share) | $ / shares	589.15
Vested (in USD per share) | $ / shares	339.22
Forfeited (in USD per share) | $ / shares	438.39
Outstanding, ending balance (in USD per share) | $ / shares	$ 486.01
Aggregate Intrinsic Value
Aggregate intrinsic value, vested | $	$ 494

Net Income Per Share - Schedule

Net Income Per Share - Schedule of Basic and Diluted Net Income Per Share Attributable to Common Stockholders (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Numerator:
Net income	$ 75,350	$ 82,440
Denominator:
Weighted-average shares outstanding - basic (in shares)	200,088	196,624
Weighted-average shares outstanding - diluted (in shares)	202,800	202,268
Net income per share - basic (in USD per share)	$ 0.38	$ 0.42
Net income per share - diluted (in USD per share)	$ 0.37	$ 0.41
Common stock options
Denominator:
Potentially dilutive securities (in shares)	180	351
RSUs
Denominator:
Potentially dilutive securities (in shares)	1,892	3,671
2022 Warrants | Warrants
Denominator:
Potentially dilutive securities (in shares)	640	618
Partial settlement of 2022 Warrants (in shares)	0	206
2022 Notes | Convertible senior notes
Denominator:
Potentially dilutive securities (in shares)	0	748
Potentially dilutive securities (in shares)	0	50

Net Income Per Share - Schedu_2

Net Income Per Share - Schedule of Potentially Dilutive Securities (Detail) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	5,636	1,928
Common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	1,022	36
ESPP obligations
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	3,766	1,748
ESPP obligations
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	159	144
2022 Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	689	0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income tax provision	$ 10	$ 17

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Aug. 31, 2020	Jun. 30, 2017
Debt Instrument [Line Items]
Operating lease costs	$ 27,000,000	$ 22,000,000
Operating lease liabilities, payments	19,000,000	18,000,000
Right-of-use assets obtained in exchange for operating lease liabilities	$ 15,000,000	$ 21,000,000
Weighted-average lease remaining lease term	9 years
Weighted-average discount rate	3.00%
Undiscounted cash flows	$ 208,000,000
Unrecognized tax benefits	35,000,000
2022 Notes
Debt Instrument [Line Items]
Principal	88,000,000			$ 782,500,000
2030 Notes
Debt Instrument [Line Items]
Principal	$ 1,500,000,000		$ 1,500,000,000
Minimum
Debt Instrument [Line Items]
Operating lease term	4 years
Maximum
Debt Instrument [Line Items]
Operating lease term	13 years

Commitments and Contingencies_2

Commitments and Contingencies - Maturity of Operating Lease Liabilities (Details) $ in Millions	Mar. 31, 2022USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of 2022	$ 78
2023	105
2024	88
2025	77
2026	58
Thereafter	327
Total operating lease payments	733
Less: imputed interest	(99)
Present value of operating lease liabilities	$ 634

Information about Geographic _3

Information about Geographic Areas and Products - Geographic Disclosures (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Revenues by geography
Total revenues	$ 1,722	$ 1,360
Property and equipment by geography
Property and equipment, net	$ 798		$ 766
Percentage of U.S. revenues in North America	94.00%	94.00%
Percentage of U.S. net property and equipment in North America	82.00%		84.00%
North America
Revenues by geography
Total revenues	$ 1,116	$ 883
Property and equipment by geography
Property and equipment, net	491		$ 484
EMEA
Revenues by geography
Total revenues	434	343
Property and equipment by geography
Property and equipment, net	191		176
Asia Pacific and other
Revenues by geography
Total revenues	172	$ 134
Property and equipment by geography
Property and equipment, net	$ 116		$ 106

Information about Geographic _4

Information about Geographic Areas and Products - Subscription Revenues (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Subscription revenues	$ 1,722	$ 1,360
Digital workflow products
Segment Reporting Information [Line Items]
Subscription revenues	1,440	1,131
ITOM products
Segment Reporting Information [Line Items]
Subscription revenues	191	162
Total subscription revenues
Segment Reporting Information [Line Items]
Subscription revenues	$ 1,631	$ 1,293